...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Resverlogix’s BETonMACE Phase 3 Epigenetics Trial Completes Final Safety Visits

Two big positives about Sept DL:

- all the investment community will be back to work

- it gives them a good amount of time to get those adjudicated events in,... i assume that adds to the total patient years as well.

Share
New Message
Please login to post a reply